首页 > 抗体蛋白 > 抗体
PE anti-mouse/human CD44 Antibody
产品名称:
PE anti-mouse/human CD44 Antibody
产品类别:
抗体
产品编号:
103008
产品应用:
103008
[价格]
规格 价格 库存
200µg ¥ 2044 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
?g sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
?g sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. For ?g sizes, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  24. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  2. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  3. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  4. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  5. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  6. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  7. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  8. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  9. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  10. Wang D, et al. 2018. Immunity. 48:659. PubMed
  11. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  12. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  13. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  14. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  15. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  16. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  17. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  18. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  19. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  20. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  21. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  22. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  23. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  24. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  25. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  26. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  27. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  28. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  29. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  30. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  31. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  32. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  33. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  34. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  35. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  36. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  37. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  38. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  39. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  40. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  41. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  42. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  43. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  44. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  45. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  46. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  47. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  48. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  49. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  50. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  51. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  52. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  53. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  54. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  55. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  56. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  57. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  58. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  59. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  60. Sentman A 2011. Blood. 117:6571. PubMed
  61. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  62. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  63. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  64. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  65. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  66. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  67. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  68. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  69. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  70. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  71. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  72. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  73. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  74. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  75. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  76. K?lin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  77. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  78. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  79. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  80. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  81. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  82. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  83. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  84. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  85. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  86. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  87. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  88. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  89. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  90. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  91. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  92. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  93. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  94. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  95. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  96. Wang S, et al. 2021. Parasite. 28:13. PubMed
  97. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  98. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  99. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  100. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  101. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  102. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  103. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  104. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  105. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  106. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  107. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  108. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  109. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  110. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  111. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  112. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  113. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  114. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  115. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  116. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  117. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  118. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  119. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  120. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  121. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  122. Korin B, et al. 2020. Sleep. :43. PubMed
  123. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  124. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  125. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  126. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  127. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  128. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  129. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  130. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  131. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  132. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  133. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  134. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  135. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  136. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  137. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  138. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  139. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  140. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  141. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  142. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
RRID
AB_493686 (BioLegend Cat. No. 103023) AB_312958 (BioLegend Cat. No. 103007) AB_493687 (BioLegend Cat. No. 103024) AB_312959 (BioLegend Cat. No. 103008)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线